3-((1,1-DIOXIDO-2,3,4,5-TETRAHYDROBENZO[F][1,2,5]THIADIAZEPIN-8-YL)OXY)-2-FLUOROACRYLIC ACID DERIVATIVES AS SODIUM TAUROCHOLATE CO-TRANSPORTING POLYPEPTIDE (NTCP) INHIBITORS FOR THE TREATMENT OF CHOLESTASIS
Publication
EP2024163962A1
Kind: A1
Mar 18, 2026
Applicants
Hemoshear Therapeutics, Inc.
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C07D 285/36 20060101AFI20240809BHEP
A61K 31/554 20060101ALI20240809BHEP
A61P 1/16 20060101ALI20240809BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR